Farms.com Home   News

Marketing Risks Key Concern For Producers

Farm Credit Canada surveyed producers back in July on Risk Management and says the majority have strategies in place.
 
Craig Klemmer, FCC’s Principal Agricultural Economist says the survey showed 67% of farm operators reported a high level of concern for marketing risk, while 60% were concerned with production risk and 53% with financial risks.
 
“We’re constantly concerned by what the markets are doing, and what prices we’re going to see for our production. So, no big surprise that marketing risk tops the board.”
 
Klemmer says the good news is most producers are in a solid financial position to withstand short-term impacts on their business.
 
Marketing risks – like price and market access - were most prominent among beef, grains and oilseed sector producers at 74%, followed by those in the fruit, vegetable and greenhouse sector at 58% and the supply managed sectors of dairy at 55% and poultry at 53%.
 
Ensuring there is sufficient working capital was the most prominent financial concern across all sectors, followed by unfavourable changes in interest rates and meeting debt payment obligations.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.